Catechol O-methyltransferase pharmacogenomics: human liver genotype–phenotype correlation and proximal promoter studies
Jianping Zhang(Mayo Clinic), Richard M. Weinshilboum(Mayo Clinic), Anthony Batzler(Mayo Clinic in Florida), Gregory D. Jenkins(University of Minnesota Rochester), Daniel J. Schaid(Mayo Clinic), Irene Moon(Mayo Clinic), Yanhong Wu(Shandong University of Technology), Yuan Ji(Jinan University), Linda L. Pelleymounter(Mayo Clinic), Oreste E. Salavaggione(Mayo Clinic)
Cited by 13
Related Papers
Implementing genomic medicine in the clinic: the future is here
|Genetics in Medicine|2013|581
Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss
|Nature Genetics|2011|399
Scapuloperoneal spinal muscular atrophy and CMT2C are allelic disorders caused by alterations in TRPV4
|Nature Genetics|2009|274
Efficacy of Contralateral Prophylactic Mastectomy in Women With a Personal and Family History of Breast Cancer
|Journal of Clinical Oncology|2001|264
The Pharmacogenetics Research Network: From SNP Discovery to Clinical Drug Response
|Clinical Pharmacology & Therapeutics|2007|243